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An Investigation into the Factors Influencing Drug
Release from Hydrophilic Matrix Tablets Based
on Novel Carbomer Polymers
Jelena Parojcˇic´, Zorica --Duric´, Milica Jovanovic´, and Svetlana Ibric´
Institute of Pharmaceutical Technology, Faculty of Pharmacy, Belgrade, Yugoslavia
Drug release from hydrophilic matrix tablets can be strongly
influenced by the proportion of matrix forming polymer and the
dimensions and geometry of the tablets. A complete two-factor,
three-level factorial design, followed by multiple regression anal-
ysis and response surface methodology, was applied to investigate
the influence of polymer level and tablet size on drug release kinet-
ics from hydrophilic matrix tablets prepared with Carbopol 971P
and Carbopol 71G. Tablet diameter, radius-to-height ratio, tablet
surface area, and surface-area-to-volume ratio were evaluated as
independent variables in terms of their applicability to characterize
tablet size and geometry. The results indicate that it may be possi-
ble to control the rate of drug release by modifying the proportion
of carbomer in tablets and tablet dimensions. The practical benefit
of these simulations is to optimize the geometry and dimensions of
a controlled release device and reduce the number of experiments
involved in the development of new controlled release dosage forms.
Keywords Carbomer, Dissolution, Drug Delivery, Hydrophilic
Matrix Tablet, Paracetamol, Sustained Release
Hydrophilic matrix tablets are among the most widely used
controlled release dosage forms for oral delivery due to their low
cost and ease of fabrication. Drug release from hydrophilic ma-
trix tablets upon contact with dissolution media or physiological
fluids involves hydratation of tablet surface and formation of the
gel layer that swells imbibing additional amount of water. The
dissolved drug diffuses through the gel layer and hydratation
and swelling progress into the tablet core. It could be expected
that these processes are dependent on the type and proportion
of the polymer used as a controlled release agent, as well as the
tablet geometry and dimensions. The subject of tablet size and
shape should be considered both from the physiological and the
manufacturers point of view.
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Channer and Virjee (1986) investigated the influence of tablet
size and shape on transit time through the esophagus and found
that large oblong tablets had significantly lower transit time
compared with large plain tablets, whereas the transit time of
small and medium tablets was lower than that for large tablets
irrespective of their shape. Also, the residence time of dosage
form in stomach could depend on the size of the dosage form
(Wilson 1998). From the formulators point of view, tablet size
and shape should be evaluated regarding required dose of the ac-
tive substance, content of excipients, mechanical characteristics
of the tablets, accessibility of tableting tools of different sizes
and shapes, and above all the targeted drug release profile.
Several researchers (Siepmann et al. 1998, 2000; Siepmann,
Streubel, and Peppas 2002; Reynolds, Mitchell, and Balwinski
2002; Karasulu, Ertan, and Kose 2000; Kim 1995) investigated
the effect of matrix geometry on drug release from sustained
release dosage forms. They have mostly focused on application
and evaluation of hydroxypropylmethylcellulose (HPMC) as a
controlled release agent. The selection of the parameter that
appropriately characterizes the tablet geometry is questionable.
Tablet size is usually expressed by the tablet radius or tablet
weight, but it appears that tablet height as well as the tablet
surface area and volume should be evaluated. Siepmann et al.
(2000) examined the effect of the aspect ratio (radius/height) and
the size of cylindrical matrices on drug release and reported that
release from small tablets is faster than from large cylindrical
tablets due to the higher relative surface area (absolute surface
area/absolute volume). Reynolds et al. (2002) studied the effect
of relative surface area of the tablets on drug release pattern
and concluded that this parameter is valuable when comparing
relative drug release from tablets of varying shapes.
Considering the apparent differences in the behavior of hy-
drophilic matrices prepared with HPMC and carbomer poly-
mers upon contact with dissolution medium, i.e., the extensive
swelling of carbomer matrices, the effect of polymer concen-
tration, and matrix geometry for tablets based on carbomer
resins should be evaluated. Some authors evaluated the effect
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of polymer level on drug release, from carbomer matrix tablets,
without considering the effect of tablet size (Khan and Zhu 1999;
Huang and Schwartz 1995; Fereira et al. 1995; Perez-Marcos
et al. 1995).
Carbomers, synthetic high molecular weight acrylic acid poly-
mers cross-linked with polyalkenyl polyether and commercially
available under the brand name of Carbopol©R , are not new in sus-
tained release technology but are still interesting. Most of the
work done on the evaluation of carbomers used the Carbopol
934 and Carbopol 974P polymers. Novel, toxicologically pre-
ferred Carbopol 971P and technologically improved Carbopol
71G polymers were used in this study.
The nonsalicylate analgesic and antipyretic drug, paraceta-
mol, which is voluminous and poorly compressible, was used as
a model substance. Paracetamol is generally classified as a drug
with high solubility that shows high permeability throughout
the intestinal tract, meeting the criteria as a class I drug accord-
ing to the Biopharmaceutics Classification System (Amidon and
Lobenberg 2000). The absorption of class I drugs should depend
on their in vivo dissolution, controlled by the kinetics of drug
release from the dosage form.
To statistically evaluate the effect of polymer content and tablet
size, factorially designed experiments were conducted, followed
by multiple regression analysis and response surface methodol-
ogy (Box, Hunter, and Hunter 1978; Montgomery 1997).
MATERIALS AND METHODS
The following materials were obtained from commercial sup-
pliers and used as received: paracetamol (Merck, Germany), Car-
bopol 971P, Carbopol 71G (BFGoodrich, USA), lactose mono-
hydrate (Fluka Chemie, Switzerland), polivinylpirolidone
(Kollidon 30, BASF, Germany), microcrystalline cellulose (Em-
cocell XLM 90, Penwest, USA), collodial silicium dioxide
(Aerosil 200, Degussa, Germany), and sodium stearyl fumarate
(Pruv, Penvest, USA).
TABLE 1
Experimental matrix with the real and coded values of investigated factors and response variable for samples prepared
with Carbopol 971P
Factor levels
X1 X2 Y
Sample Coded Real Coded Real D5h (%)
m (mg) d (mm) h (mm) r/h P (mm2) V (mm3) P/V
P1 −1 7.5 −1 275 9 4.24 1.0613 246.99 269.60 0.9161 96.08
P2 0 15 −1 275 9 4.26 1.0563 247.56 270.87 0.9139 66.24
P3 1 22.5 −1 275 9 4.66 0.9657 259.00 296.62 0.8736 50.51
P4 −1 7.5 0 550 12 4.39 1.3667 391.50 496.24 0.7889 44.73
P5 0 15 0 550 12 4.46 1.3453 394.13 504.16 0.7817 37.78
P6 1 22.5 0 550 12 4.96 1.2097 412.97 560.68 0.7365 28.79
P7 −1 7.5 1 825 15 4.44 1.6892 562.37 784.22 0.7171 43.12
P8 0 15 1 825 15 4.60 1.6304 569.91 812.48 0.7014 34.75
P9 1 22.5 1 825 15 4.88 1.5369 583.10 861.93 0.6765 26.28
Experimental Design
Two separate experimental runs including 9 samples were
performed according to the 32 experimental design. Addition-
ally, the central experiment was done in triplicate to determine
validity of the obtained mathematical models. The indepen-
dent variables were proportion of Carbopol 971P or Carbopol
71G (X1) and tablet size (X2). The proportion of polymer was
7.5, 15.0, or 22.5%. Tablet size was expressed as tablet ra-
dius, radius-to-height ratio (aspect ratio), tablet surface area, and
surface-area-to-volume ratio (designated as relative surface area).
The selected response variable (Y) was percent of drug released
after 5 hr of investigation (D5h). The experimental matrix, real
and coded values of investigated factors, and response vari-
able are presented in Tables 1 and 2 for samples prepared with
Carbopol 971P and Carbopol 71G, respectively.
After performing the experiments, multiple linear regression
was applied to evaluate the regression coefficients of the math-
ematical model that included the linear and quadratic terms of
both factors investigated, as well as the interaction factor:
Y = b0 + b1X1 + b2X2 + b3X21 + b4X22 + b5X1X2 [1]
Student’s t-test was applied to each term of the quadratic model
to evaluate their significance. Only terms that were significant
were included in the final model. An experimental matrix was,
after the estimation of regression coefficients, used to charac-
terize the results by response surface methodology. Response
surface and contour plots were drawn to visualize the effect of
investigated factors.
Preparation of Tablets
Tablet samples were prepared using conventional wet granu-
lation method. A paracetamol–lactose mixture (80:20) was gran-
ulated using 5% polyvinylpyrrolidone aqueous dispersion. The
sustained release agent was added extragranularly, as well as
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TABLE 2
Experimental matrix with the real and coded values of investigated factors and response variable for samples prepared
with Carbopol 71G
Factor levels
X1 X2 Y
Sample Coded Real Coded Real D5h (%)
m (mg) d (mm) h (mm) r/h P (mm2) V (mm3) P/V
G1 −1 7.5 −1 275 9 3.85 1.1688 235.97 244.80 0.9639 97.52
G2 0 15 −1 275 9 3.85 1.1688 235.97 244.80 0.9639 74.30
G3 1 22.5 −1 275 9 3.9 1.1538 237.38 247.98 0.9573 47.68
G4 −1 7.5 0 550 12 4.45 1.3483 393.76 503.03 0.7828 47.79
G5 0 15 0 550 12 4.5 1.3333 395.64 508.68 0.7778 37.15
G6 1 22.5 0 550 12 4.55 1.3187 397.52 514.33 0.7729 27.90
G7 −1 7.5 1 825 15 4.49 1.6704 564.73 793.05 0.7121 45.69
G8 0 15 1 825 15 4.44 1.6892 562.37 784.22 0.7171 31.97
G9 1 22.5 1 825 15 4.4 1.7045 560.49 777.15 0.7212 27.30
other excipients, mixed and compressed in an excenter tablet ma-
chine (Erweka Korsch EK0, Germany) using flat round punches
of various diameters (9, 12, and 15 mm). The compression pres-
sure was adjusted to provide tablets with hardness between 50
and 60 kN. The set of tablet samples prepared with Carbopol
971P was designated as samples P1-P9, while tablet formula-
tions containing Carbopol 71G were designated as samples G1-
G9. To evaluate the effect of tablet height, additional samples
of tablets containing 22.5% of Carbopol 71G, with diameters of
12 mm and 3 mm (sample G63), 5 mm (sample G65), and 6 mm
(sample G66) tablet height were prepared.
Drug Release Study
The release experiments were conducted in the rotating pad-
dle apparatus (Erweka DT 70, Germany), in 1000 ml of distilled
water 37◦C, at 50 rpm. Then 3-ml samples were withdrawn
at 1 hr intervals, filtered, properly diluted, and assayed UV-
spectrophotometrically (spectrophotometer Cary 50, Varian,
Australia) at 243 nm. Six tablets were studied for each formula-
tion. Upon formation of the gel layer at the tablet surface, tablets
stuck to the vessel of the dissolution apparatus, which signifi-
cantly decreased the drug release rate as the surface area of the
matrix exposed to the medium was reduced. To prevent such
sticking, wire helix was used that did not restrict the contact of
the tablet with the dissolution medium.
Drug release kinetics were evaluated using the following ex-
ponential equation proposed by Ritger and Peppas (1987):
Mt/M∞ = ktn [2]
where Mt/M∞ is the fraction of drug released at time t, k is the
kinetic constant (drug release rate constant), which incorporates
structural and geometrical characteristics of the controlled re-
lease system, and n is the diffusional release exponent indicative
of the release mechanism. The experimental data were fitted to
the proposed equation using nonlinear regression (Levenberg-
Marquardt algorithm, Microcal Origin 5.0).
RESULTS AND DISCUSSION
Drug release profiles obtained for tablet samples prepared
with Carbopol 971P (samples P1-P9) and Carbopol 71G (sam-
ples G1-G9) are presented in Figures 1 and 2, respectively. More
homogenous and uniform matrix swelling was observed in the
tablets prepared with Carbopol 971P, whereas with Carbopol
71G matrices, the disentanglement of polymer chains was much
more pronounced as well as more intensive swelling in axial
direction. An overall trend of more sustained drug release could
be observed in Carbopol 971P tablets during the first hours of
investigation, while Carbopol 71G, used as a controlled release
agent, tended to maintain the integrity of the matrix and thus
prolong drug release. Complete drug release (i.e., >80%) dur-
ing 8 hr of investigation was observed in “small” tablets and
medium and large tablets containing 7.5% of Carbopol 71G.
The drug release was prolonged over 10 hr in medium and
large tablets containing 22.5% of Carbopol 71G and medium
and large tablets containing both 15% or 22.5% of Carbopol
971P.
The obtained values of diffusional exponent (n) varied from
1.1818 to 2.2613 for tablets prepared with Carbopol 971P and
from 1.5412 to 2.6443 for Carbopol 71G tablets. Considering the
cylindrical shape of the tablets, the n value of 0.89 indicates the
zero-order drug release kinetics, while n > 0.89 denotes super
case II transport (Ritger and Peppas 1987). According to the
obtained n values, the drug release kinetics could be described
as swelling and relaxation of the polymer controlled following
the super case II transport.
Multiple regression analysis and analysis of variance revealed
that within the investigated experimental field, the effect of
both polymer content and tablet size significantly influenced the
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FIG. 1. Drug release profiles obtained for tablets with varying polymer content and tablet size prepared with Carbopol 971P (samples P1-P9).
percent of drug released after 5 hr of investigation. The effect of
concentration was linear, while the tablet size exhibited both the
linear and quadratic effect. The effect of interaction factor also
was significant in the majority of studied cases. The regression
coefficients of quadratic models calculated by multiple regres-
sion were found to be significant (p < .05) and coefficients
of determination for each model are reported in Tables 3 and 4
FIG. 2. Drug release profiles obtained for tablets with varying polymer content and tablet size prepared with Carbopol 71G (samples G1-G9).
for series of tablets prepared with Carbopol 971P and Carbopol
71G, respectively. The highest coefficient of determination for
the samples prepared with Carbopol 971P was obtained when
aspect ratio was selected as the parameter of tablet size, while
for the samples prepared with Carbopol 71G, the best fit was
obtained for model in which relative surface area was used to
characterize the tablet size.
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TABLE 3
Summary of the multiple regression analysis for tablet samples prepared with Carbopol
971P (samples P1-P9)
Tablet dimensions evaluated as X2 factor
Regression
coefficient Diameter Radius/height Surface area Surface area/volume
b0 491.187 670.294 242.147 845.330
b1 −5.647 −10.590 −1.727 −1.43
b2 −60.817 −755.649 −0.783 −2140.310
b3 — — — —
b4 2.083 226.373 0.0008 1446.60
b5 0.319 6.373 — —
R2 0.9789 0.9938 0.9402 0.9507
The mathematical models obtained for these two sets of
tablets, based on tablet diameter and tablet surface area, were
almost identical in regard to the calculated set of regression
coefficients. Although high coefficients of determination were
obtained for model based on the tablet diameter as parameter
describing the tablet size, it would not allow the accurate pre-
diction of drug release from matrices of different height. Thus,
aspect ratio and relative surface area as parameters encountering
both tablet diameter and height should be further evaluated.
The response surface and contour plots of drug released af-
ter 5 hr versus polymer content versus tablets aspect ratio for
set of tablets prepared with Carbopol 971P and Carbopol 71G
are given in Figures 3a and 4a, respectively. Accordingly, the
relationship between percent of drug released after 5 hr versus
polymer content versus relative surface area of the tablets is pre-
sented through the response surface and contour plots presented
in Figures 3b and 4b, for the two set of tablets.
The drug release profiles observed when studying the effect
of tablet height are presented in Figure 5. Although the percent
of drug released from samples with various tablet heights (and
weights) were different as illustrated in Figure 5b, the actual
amounts of drug released were almost identical during the first
5 hr of investigation (Figure 5a). These results were inconsistent
TABLE 4
Summary of the multiple regression analysis for tablet samples prepared with Carbopol
71G (samples G1-G9)
Tablet dimensions evaluated as X2 factor
Regression
coefficient Diameter Radius/height Surface area Surface area/volume
b0 469.660 956.440 253.212 314.849
b1 −6.152 −2.250 −4.463 5.121
b2 −55.507 −1183.350 −0.726 −853.553
b3 — — — —
b4 1.829 389.51 0.0006 676.723
b5 0.349 — 0.0064 −8.571
R2 0.9808 0.8769 0.9599 0.9866
with those reported by Siepmann et al. (2000) for hydroxypropy-
lmethylcellulose matrix tablets, in which, with respect to vari-
able tablet height, similar results were obtained for percent of
drug released, while the amounts of drug released were markedly
different.
In the case of “thin” (h = 3 mm) tablets, complete drug release
and disintegration of matrix occurred after 6 hr, while in the
case of “thicker” tablets, with 5 mm and 6 mm tablet height,
drug release proceeded until 12 hr or 14 hr of investigation,
respectively.
These results indicate that in the case of Carbopol 71G matrix
tablets, within the usual range of radius/height ratio, the effect
of more intensive axial than radial swelling resulted in superim-
posable drug release profiles during first hours of investigation,
regardless of tablet height. However, tablet height was the fac-
tor determining the time interval in which the integrity of the
matrix remained intact, thus influencing the overall sustained
release period.
To evaluate the predictability of the obtained mathematical
models, the internal and external predictability values were as-
sessed according to the percent prediction error:
%PE = [|Yobs − Ypred|/Yobs] × 100 [3]
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FIG. 3. Response surface and contour plot of (a) D5h vs. polymer content vs. aspect ratio; (b) D5h vs. polymer content vs. relative surface area for samples
prepared with Carbopol 971P.
FIG. 4. Response surface and contour plot of (a) D5h vs. polymer content vs. aspect ratio; (b) D5h vs. polymer content vs. relative surface area for samples
prepared with Carbopol 71G.
FIG. 5. Effect of the initial tablet height on the (a) resulting absolute amounts of drug released; (b) resulting relative amounts (%) of drug released from Carbopol
71G matrix tablets of various height. 
: 3 mm, ◦: 5 mm; ×: 6 mm.
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TABLE 5
Predicted and observed values of D5h for samples with different tablet heights
Predicted D5h values (%PE)
Sample Based on d Based on r/h Based on P Based on P/V
Experimentally
observed D5h values
G6 22.76 (18.42) 22.82 (18.21) 16.25 (41.76) 25.56 (8.39) 27.90
G63 22.76 (56.70) 97.16 (84.86) 24.45 (53.48) 60.39 (14.90) 52.56
G65 22.76 (53.62) 52.88 (70.80) 14.36 (53.62) 27.10 (12.47) 30.96
G66 22.76 (52.93) 125.31 (389.88) 12.04 (52.93) 28.31 (10.67) 25.58
G8 34.82 (8.91) 35.20 (10.10) 21.73 (32.03) 35.38 (10.67) 31.97
where Yobs is the experimentaly observed value of the response
variable and Ypred is the value predicted according to the pro-
posed mathematical model. The internal predictability was esti-
mated from the results used to develop the mathematical model
(samples G6 and G8). The external predictability was anticipated
using data from the additional samples of tablets with various
tablet height (G63, G65, G66). The predicted values of percent
of drug released after 5 hr of investigation calculated according
to the proposed mathematical models and percent prediction er-
ror calculated for each example, as well as the observed values,
are presented in Table 5. Good agreement between theory and
experiment was observed in the mathematical model based on
relative surface area as the parametar describing tablet dimen-
sions, quantified by a percent prediction error ranging from 8.39
to 14.90%
CONCLUSION
Our results indicate that it may be possible to control the
rate of drug release by modifying the proportion of carbomer in
tablets and tablet dimensions. The kinetics of drug release de-
pended on the type of polymer, as well as on the polymer content
and tablet geometry. Although chemically identical, Carbopol
971P and Carbopol 71G exhibit different drug release patterns
due to the technological modifications involved in the manu-
facture of Carbopol 71G. The present results suggest that the
release kinetics are mostly regulated by a swelling-controlled
diffusion process, because most of the drug is released while a
large portion of the polymer matrix remains intact.
Both the content of polymer and tablet geometry and dimen-
sions should be evaluated to optimize the formulation with the
targeted drug release pattern. Although the tablet diameter seems
to be the prevalent tablet size parameter determining the drug
release rate, we found that relative surface area is a more rele-
vant term for comparison of tablets of varying height, which also
is expected to be useful for comparison of tablets of different
shape. The practical benefit of these simulations is to optimize
the geometry and dimensions of a controlled release device and
reduce the number of experiments involved in the development
of new controlled release dosage forms.
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